SEC 13F Intelligence

Artal Group S.A. / RVMD

Artal Group S.A.’s Revolution Medicines Inc Position

Does Artal Group S.A. own Revolution Medicines Inc (RVMD)? Not currently — the last reported position was 1.02M shares worth $39M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$39M
Q2 2024
Shares
1.02M
% of Portfolio
+1.01%
Quarters Held
7
position exited

Position History RVMD

Reported value by quarter
Q4 ’22: $23,820Q4 ’22Q1 ’23: $44,858Q1 ’23Q2 ’23: $64,243Q2 ’23Q3 ’23: $70,023Q3 ’23Q4 ’23: $48,640Q4 ’23Q1 ’24: $43MQ1 ’24Q2 ’24: $39MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20241.02M$39M+1.01%
Q1 20241.32M$43M+1.08%
Q4 20231.70M$48,640+1.62%
Q3 20232.53M$70,023+3.00%
Q2 20232.40M$64,243+1.99%
Q1 20232.07M$44,858+2.67%
Q4 20221.00M$23,820+1.33%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artal Group S.A.’s full portfolio or all institutional holders of RVMD.